Guess those docs haven't heard or care about informed consent.... -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] Behalf Of Fritz, Donna Sent: Thursday, December 22, 2005 3:05 PM To: Mats Strömberg; Venous Subject: RE: Spam: Breast cancer VAD choice
I'm addressing bullet point #3. I think you will have to look at what chemo is giving in your area for breast ca treatment. We're doing adriamycin + cytoxan, followed by a taxane, usually taxol. It's usually given on an every 3 week basis for several months. It seems an ideal circumstance for a port. I think your line has to match the type of therapy patients will receive. For colon patients receiving continuous 5FU, an externalized tunneled cath seems more suited. Unfortunately, our physicians make the choice without presenting options to the patient, but this is kind of how they decide. No evidence basis here. Donna Fritz, RN, MN, OCN Oncology CNS -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] Behalf Of Mats Strömberg Sent: Thursday, December 22, 2005 11:32 AM To: Venous Subject: Spam: Breast cancer VAD choice Dear listers, I am going to write about half a page on vascular access device choice for breast cancer patients. It is part of a larger set of guidelines for breast cancer. The things I would like to address are: - The importance of early assessment - The advantages of central venous access devices (like better hemodilution preserving the veins, lower risk for extravasation) - The individual advantages of implanted ports, PICCs and Hickman lines - When to opt for peripheral access Is this the things that I should address? I need to show the evidence base for everything. What is the evidence for these things? What is the important litterature to use as references? Thanks in advance Mats in Stockholm ---- Mats Strömberg, RN, Research nurse Dept. of Oncology Karolinska University Hospital, Solna SE-171 76 Stockholm E-mail: [EMAIL PROTECTED] Phone int: +46 8 517 76376 Mobile phone int: +46 70 471 6661 *****************************************************************************This communication is for the use of the intended recipient only. It may contain information that is privileged and confidential. If you are not the intended recipient of this communication, any disclosure, copying, further distribution or use thereof is prohibited. If you have received this communication in error, please advise me by return e-mail or by telephone and delete/destroy it.***************************************************************************** ************************************************************* The information contained in this E-mail transmission is intended only for the use of the individual or entity to whom it is addressed. It may contain privileged, confidential, and protected health information. If you received it in error, you are on notice of its status. Please notify us immediately by reply e-mail and then please delete this message from your system. Please do not copy it or use it for any purposes, or disclose its contents to any other person. To do so could violate state and Federal privacy laws. Thank you for your cooperation. Please contact the sender if you need assistance.
